The electroencephalograms (EEGs) of 22 patients suffering from hereditary DRPLA were studied. Epileptoform patterns were observed in 14 patients (63.6%) with epileptic seizures. The epileptoform patterns most frequently observed were those atypical spike‐wave complexes. Slow wave bursts were seen in 18 patients (81.8%). Photosensitivity was revealed in six (27.3%) patients, all of whom presented progressive myoclonus epilepsy (PME) syndrome. Abnormal background activity was evident in 17 (77.3%) patients. These abnormalities in EEG were more severe in patients in the PME type than those of the A (ataxia) and AE (ataxia and epilepsy) types.
Phenotypes of apolipoprotein E (apoE) were determined with an isoelectric focusing method in 39 patients with sporadic Alzheimer's disease (AD), 3 8 patients with dementia from cerebrovascular disease (CVD), and 100 healthy subjects without hyperlipidemia. There was a striking difference in the distribution of apoE phenotypes between patients with AD and healthy subjects (p<0.001). Such a difference was attributable to different frequencies of phenotype E4/3 and E3/3. The apoE4/ 3 phenotype was detected in 38.5% (15 of 39) patients with AD, more than 3 times higher than in healthy subjects (12.0%, 12 of 100). In contrast, apoE3 / 3 phenotype, a wild type apoE phenotype, was detected in 81.0% (81 of 100) of healthy subjects but only in 38.5% (15 of 39) of patients with AD. The frequency of apoE-E4 allele assessed on the basis of obtained apoE phenotypes in patients with AD (0.269) was significantly higher than that in healthy subjects (0.08, p<0.001) and in patients with dementia from CVD (0.118, p<0.01). Furthermore, the frequencies of apoE-E4 in AD were 0.190 in patients older than 70 years and 0.333 in patients younger than 70 years. These results indicate a strong association between apoE-e4 and sporadic AD and suggest that apoE-e4 assessed from apoE phenotypes may be a possible risk factor for AD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.